Alexion Pharmaceuticals Contact Pages on BioPortfolio:

Biotechnology News Vertex Pharmaceuticals Search
Author: insider More about ALXN: Insider Trades Writers Compensation Program - Writers Wanted CEO of Alexion Pharmaceuticals Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio Biotechnology BioNews : live article
Alexion Pharmaceuticals, Inc. is a biotechnology company working to develop and ... If you need more information about this story, please contact NewsEdge ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotechnology News Dentsply International Search
Eli Lilly and Company PharMerica Corporation Alcon, Inc. Hoffmann - La Roche Ltd . QIAGEN N.V.. Alexion Pharmaceuticals, Inc.. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Alexion Pharmaceuticals Incorporated - Profile
(http://www.bioportfolio.com/biocorporate/346-Alexion+Pharmaceuticals+ Incorporated.html). Contact Details: 352 Knotter Drive. Cheshire ...
http://www.bioportfolio.com/biocorporate/346-Alexion+Pharmac...

BioPortfolio - Alexion Antibody Technologies, Inc. - Profile
17 Nov 2009 ... Contact Details: 3985 Sorrento Valley Blvd Ste, A. San Diego ... capacity of Alexion Pharmaceuticals, forming a powerhouse in antibody ...
http://www.bioportfolio.com/biocorporate/18312-Alexion+Antib...

BioPortfolio - Alexion Antibody Technologies, Inc.
Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a
...
http://www.bioportfolio.com/biocorporate/18312-Alexion_Antib...

BioPortfolio - Hoffmann La Roche
11 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. ("Alexion," the ... we can enable you to contact around 682 individuals from Hoffmann La Roche ...
http://www.bioportfolio.com/biocorporate/5017-Hoffmann_La_Ro...

BioPortfolio - Phoenix Pharmaceuticals Incorporated
Alexion Pharmaceuticals To Present At Credit Suisse's 2009 Healthcare Conference ; ... Contact BioPortfolio for a quote for a customised Excel verision of ...
http://www.bioportfolio.com/biocorporate/8330-Phoenix_Pharma...

BioPortfolio - Link Pharmaceuticals - Profile
Contact Details: PO Box 135. Avalon Beach. New South Wales. 2107. Australia ... Alexion Pharmaceuticals to Present Soliris Data at Annual ASH Meeting ...
http://www.bioportfolio.com/biocorporate/6495-Link+Pharmaceu...

BioPortfolio - Gaco Pharmaceuticals. - Profile
Contact Details: 65 Dilkusha Commercial Area. Dhaka. 1000. Bangladesh ... Alexion Pharmaceuticals (ALXN) Bullish Technical Alert - Trend Up 11.7% ...
http://www.bioportfolio.com/biocorporate/23227-Gaco%25252525...

Results from other life science and pharmaceutical sites:

Alexion Pharmaceuticals Inc. Reports Phase III Results for PRIMO ...
Contact: Alexion Pharmaceuticals, Inc. Leonard Bell, M.D. Chief Executive Officer (203) 272-2596. Rx Communications Patricia Garrison (Scientific Media)
...
http://www.biospace.com/news_story.aspx?NewsEntityId=3409...

Alexion to Present at Credit Suisse's 2009 Healthcare Conference ...
5 Nov 2009 ... Contact: Alexion Pharmaceuticals, Inc. Irving Adler, 203-271-8210. Sr. Director, Corporate Communications or. Makovsky + Company ...
http://biz.yahoo.com/bw/091105/20091105006309.html?.v=1...

BioSpace - Alexion Pharmaceuticals Inc. News, Search Jobs, Events
Alexion Pharmaceuticals Inc. (ALXN) Release: Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of Patients With PNH at the
...
http://www.biospace.com/company_profile.aspx?CompanyId=1684...

Researchers to Present Additional Data on Soliris® (eculizumab ...
10 Nov 2009 ... (BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN - News) today announced that ... Alexion Pharmaceuticals, Inc. is a biopharmaceutical company
working to develop and ... Contact: Alexion Pharmaceuticals, Inc. ...
http://biz.yahoo.com/bw/091110/20091110006728.html?.v=1...

Alexion Pharmaceuticals Inc. Release: Researchers to Present ...
11 Nov 2009 ... Alexion Pharmaceuticals Inc. (ALXN) Release: Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of Patients ...
http://www.biospace.com/news_story.aspx?NewsEntityId=162507...

Yale Biotechnology & Pharmaceutical Society - Yale-New Haven ...
3 Mar 2007 ... If you register and cannot make it, please contact our Yale-New Haven Biotechnology ... Alexion Pharmaceuticals. 10:15AM – 11:00AM ...
http://www.yale.edu/ybps/symposiumandcareerfair2005.htm...

Alexion Pharmaceuticals Inc. to Present at Credit Suisse's...
5 Nov 2009 ... (BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion ...
http://www.biospace.com/news_story.aspx?NewsEntityId=161978...

Discovery and development of the complement inhibitor eculizumab ...
1 Nov 2007 ... A recently developed, humanized monoclonal antibody directed against complement component C5, eculizumab (Soliris; Alexion Pharmaceuticals ...
http://www.nature.com/nbt/journal/v25/n11/abs/nbt1344.html...

Jobs and Internships 03/31/08
Alexion Pharmaceuticals Inc. Rhode Island Smithfield 3/31/2008 ... Recruiting Contact: Please submit your resume to www.sig.com/careers under Job # 1221BR ...
http://yale.edu/ybps/jobs/042608jobs.doc...

Cancer Gene Therapy - Abstract of article: Positron emission ...
22 Oct 2004 ... aCurrent address: Alexion Pharmaceuticals, Inc., 352 Knotter Drive, Cheshire, CT 06410, USA. bCurrent address: RibX Pharmaceuticals, Inc., ...
http://www.nature.com/cgt/journal/v12/n1/abs/7700779a.html...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.